IEEE - Institute of Electrical and Electronics Engineers, Inc. - Incorporating Long-Acting Insulin Glargine Into the UVA/Padova Type 1 Diabetes Simulator for In Silico Testing of MDI Therapies

Author(s): Roberto Visentin ; Michele Schiavon ; Clemens Giegerich ; Thomas Klabunde ; Chiara Dalla Man ; Claudio Cobelli
Sponsor(s): IEEE Engineering In Medicine and Biology Society
Publisher: IEEE - Institute of Electrical and Electronics Engineers, Inc.
Publication Date: 1 October 2019
Volume: 66
Page(s): 2,889 - 2,896
ISSN (Electronic): 1558-2531
ISSN (Paper): 0018-9294
DOI: 10.1109/TBME.2019.2897851
Regular:

Objective: Glargine 100 U/mL (Gla-100) and 300 U/mL (Gla-300) are long-acting insulin analogs providing basal insulin supply in multiple daily injection (MDI) therapy of type 1 diabetes (T1D).... View More

Advertisement